National Vision (NASDAQ:EYE) Sets New 1-Year Low – Should You Sell?

Shares of National Vision Holdings, Inc. (NASDAQ:EYE) hit a new 52-week low on Thursday . The company traded as low as $14.75 and last traded at $16.92, with a volume of 13323034 shares changing hands. The stock had previously closed at $20.94.

Trending Headlines about National Vision

Here are the key news stories impacting National Vision this week:

• Positive Sentiment: National Vision reported Q1 EPS of $0.45, topping expectations of $0.43 and improving from $0.34 a year ago, which suggests stronger profitability. Article Title
• Positive Sentiment: Quarterly revenue rose 6.6% year over year to $543.9 million, showing continued sales growth despite a modest miss versus estimates. Article Title
• Neutral Sentiment: The company reaffirmed FY 2026 guidance of $0.85 to $1.09 EPS and $2.0 billion to $2.1 billion in revenue, which is broadly in line with expectations but leaves limited upside versus consensus. Article Title
• Negative Sentiment: Revenue of $543.9 million missed analyst estimates of $545.1 million, which may cap enthusiasm after the earnings beat. Article Title
• Negative Sentiment: A shareholder-loss investigation announced by Johnson Fistel introduces legal overhang and could add uncertainty for investors. Article Title

Analyst Upgrades and Downgrades

EYE has been the subject of a number of research analyst reports. Wall Street Zen cut National Vision from a “buy” rating to a “hold” rating in a research report on Saturday, March 28th. Wolfe Research set a $35.00 price target on National Vision in a research report on Wednesday, March 4th. Zacks Research cut National Vision from a “strong-buy” rating to a “hold” rating in a research report on Thursday, March 12th. Citigroup raised their price target on National Vision from $35.00 to $40.00 and gave the company a “buy” rating in a research report on Thursday, March 5th. Finally, Morgan Stanley raised their price target on National Vision from $26.00 to $30.00 and gave the company an “equal weight” rating in a research report on Thursday, January 15th. Seven equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $32.08.

National Vision Trading Down 19.2%

The stock has a market cap of $1.36 billion, a PE ratio of 45.73, a PEG ratio of 1.58 and a beta of 1.18. The business has a 50-day moving average of $25.25 and a 200 day moving average of $26.42. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.33 and a current ratio of 0.55.

National Vision (NASDAQ:EYE) last posted its quarterly earnings data on Wednesday, May 13th. The company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The firm had revenue of $543.88 million during the quarter, compared to analysts’ expectations of $545.09 million. National Vision had a return on equity of 5.15% and a net margin of 1.49%.The firm’s quarterly revenue was up 6.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.34 EPS. National Vision has set its FY 2026 guidance at 0.850-1.090 EPS. Equities research analysts predict that National Vision Holdings, Inc. will post 0.66 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Chairman L Reade Fahs sold 4,071 shares of National Vision stock in a transaction dated Friday, March 6th. The stock was sold at an average price of $29.57, for a total transaction of $120,379.47. Following the completion of the sale, the chairman owned 359,359 shares in the company, valued at approximately $10,626,245.63. This trade represents a 1.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 2.40% of the company’s stock.

Institutional Trading of National Vision

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in EYE. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in National Vision by 4.4% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 46,257 shares of the company’s stock worth $591,000 after purchasing an additional 1,948 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in National Vision by 6.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 235,125 shares of the company’s stock worth $3,005,000 after purchasing an additional 13,384 shares in the last quarter. Creative Planning purchased a new stake in National Vision during the 2nd quarter worth about $395,000. Walleye Capital LLC increased its position in National Vision by 29.4% during the 2nd quarter. Walleye Capital LLC now owns 27,127 shares of the company’s stock worth $624,000 after purchasing an additional 6,170 shares in the last quarter. Finally, Cerity Partners LLC increased its position in National Vision by 13.8% during the 2nd quarter. Cerity Partners LLC now owns 16,887 shares of the company’s stock worth $389,000 after purchasing an additional 2,049 shares in the last quarter.

National Vision Company Profile

National Vision Holdings, Inc is an American optical retailer specializing in accessible vision care and eyewear. The company operates under multiple retail banners, offering comprehensive eye health services and a wide range of optical products. Since its founding in the early 1990s, National Vision has focused on providing value-driven solutions, targeting underserved and price‐conscious consumer segments.

Through its primary retail brands—including America’s Best Contacts & Eyeglasses, Eyeglass World, Optical America and Vista Optical—National Vision delivers services such as comprehensive eye examinations, prescription eyewear, contact lenses, sunglasses and lens accessories.